Bioterrorism

Mystery surrounds University of Chicago "plague death" victim
University of Chicago microbiologist died — and an autopsy revealed he had plague bacteria in his blood; the researcher was working with a weakened vaccine strain of Yersinia pestis, intended for the development of vaccines against plague
- Read more
Turning water fountains into infection control units
Toronto’s Farrow Partnership Architects sees future in infection-control units
- Read more

The state of public health and biodefense
- Read more
New business model for researching, producing vaccines
Relying on venture capital-funded biotech research is problematic when it comes to vaccines for pandemics and bioterrorism; an expert proposes a private-public partnership within the HHS Biomedical Advance Research and Development Authority
- Read more

Pennsylvania bio-terror laboratory fails inspection
Pennsylvania-based BSL-3 BioLab fails, yet again, a safety inspection; the facility was finished in 2007 but has been beset by an assortment of delays, poor construction, and breakdowns
- Read more
Scientists closer to a safer anthrax vaccine
The currently available, 40-year-old anthrax vaccine, can prevent disease, but it has significant drawbacks: Immunity is temporary, and five injections over the course of eighteen months are needed to sustain it; one in five vaccine recipients develop redness, swelling, or pain at the injection site, and a small number develop severe allergic reactions; researchers offer a better vaccine
- Read more

Obama administration emphasizes prevention in bioterrorism strategy
Experts say that the Obama administration’s approach to combating bioterrorism differs from that of the Bush administration; Bush emphasize crisis management — the ability to detect a biological event in process and to reduce its scope; prevention emphasizes actions that could be taken to stop an attack before it occurs
- Read more
Third patient dies of plague in remote Chinese town
Chinese authorities have sealed off a remote Chinese town after an outbreak of pneumonic plague; authorities have set up a cordon with a 17-mile radius around the town of Ziketan; public buses were pulled off the streets, and the police is patrolling on the streets, advising shops to close
- Read more

DHS is searching for buyers for Plum Island facility
The Plum Island Biosafety level 4 facility — the only type of research lab authorized to handle diseases that are communicable between humans and animals and for which there is no known cure — is aging; DHS has selected a Kansas site for a new, $500 million replacement; DHS is beginning to look for buyers for the Plum Island facility
- Read more
GAO slams choice of Kansas as location of new BioLab
In a critical report, the U.S. Government Accountability Office (GAO) says that the process by which DHS selected Kansas as the site for the $450 million BioLab was not “scientifically defensible”; GAO said DHS greatly underestimated the chance of accidental release and major contamination from such research; Tornado Alley may not be safe
- Read more

Judge dismisses lawsuit objecting to Kansas location of biolab
Texas Bio- and Agro-Defense Consortium sued DHS over the department’s decision to build the new BioLab Level 4 in Kansas; judge dismisses case — but without prejudice, opening the way for the consortium to refile the lawsuit later
- Read more
Inkjet printer technology to be used in biosensors
Researchers describe a method for printing a toxin-detecting biosensor on paper using a FujiFilm Dimatix Materials Printer; the method relies on a “lateral flow” sensing approach similar to that used in a home pregnancy test strip
- Read more

Biohazards to be studied in Memphis
The University of Tennessee at Memphis inaugurates a new Level 3 Biohazard lab to develop new vaccines and antibiotics
- Read more
DARPA wants to stop biothreats before they spread
DARPA is looking to accelerate the response to pathogens, stopping the bugs before they even start; the goal: persistent, universal immunity by speeding up long-term resistance to new and unknown pathogens
- Read more
Scientists block Ebola infection in cell-culture experiments
University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells; breakthrough could lead to first therapy for deadly disease
- Read more

More headlines